NCT02156440View on ClinicalTrials.gov

Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Osteoarthritis of the Knee

Interventions

DIETARY_SUPPLEMENT

SierraSil Joint Formula 14

667 mg SierraSil® hydrothermal mineral complex

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

N6A 5R8

KGK Synergize Inc., London

Sponsors

Lead Sponsor

KGK Science Inc.

All Listed Sponsors

collaborator

SierraSil Health Inc

INDUSTRY

lead

KGK Science Inc.

INDUSTRY

NCT02156440 - Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter